Ilia N Buhtoiarov

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Hodgkin Lymphoma

Stem Cell Transplantation

Prognostic Factors

Top Venues

Pediatric blood & cancer

Pediatric hematology and oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher Jon Forlenza, Jaclyn D Rosenzweig, Audrey Mauguen, Ilia N Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca J Deyell, Jamie E Flerlage, Anna R K Franklin, Jennifer Krajewski, Kasey J Leger, Lianna J Marks, Robin E Norris, Martha Pacheco, Faye K Willen, Adam Paul Yan, Paul Harker-Murray, Lisa Giulino-Roth
Brentuximab Vedotin Following Autologous Transplantation in Pediatric Patients with Relapsed/Refractory Hodgkin Lymphoma. Blood advances (2023)
Ilia N Buhtoiarov, Nkechi I Mba, Crystal D L Santos, Kathleen M McCarten, Monika L Metzger, Qinglin Pei, Rizvan Bush, Kayla Baker, Kara M Kelly, Peter D Cole
Durable remission for four pediatric patients with high-risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group. Pediatric blood & cancer 69 (6) (2022)
Anthony S Zembillas, Stefanie M Thomas, Seth J Rotz, Ilia N Buhtoiarov, Rabi Hanna
Palifermin as primary mucositis prophylaxis in patients with B-cell Non-Hodgkin lymphoma: a case series. Pediatric hematology and oncology (2021)
Ilia N Buhtoiarov
Comment on: FDG PET-CT in pediatric Langerhans cell histiocytosis: Can all birds be killed with just one stone? Pediatric blood & cancer 67 (5) (2020)
Ilia N Buhtoiarov, Anthony S Zembillas
Excessive toxicities of pegylated asparaginase in pediatric acute lymphoblastic leukemia patients with high body surface area: A call for action. Pediatric blood & cancer 68 (3) (2020)